已收盤 04-02 16:00:00 美东时间
+4.710
+1.59%
今日重点评级关注:HC Wainwright & Co.:维持NovoCure"买入"评级,目标价从47美元升至49美元;Citizens:维持Ironwood医药"跑赢大市"评级,目标价从8美元升至10美元
02-27 11:07
Top Wall Street analysts changed their outlook on these top names. For a comple...
02-26 19:45
Morgan Stanley analyst Michael Phillips downgrades RenaissanceRe Holdings (NYSE:RNR) from Overweight to Equal-Weight and maintains the price target from $310 to $310.
02-26 19:08
今日重点评级关注:杰富瑞:上调BioAge Labs评级至"买入",目标价从9美元升至62美元;RBC Capital:维持COMPASS Pathways Plc Sponsored ADR"跑赢大市"评级,目标价从21美元升至22美元
02-19 16:21
Citigroup analyst Matthew Heimermann maintains RenaissanceRe Holdings (NYSE:RNR) with a Neutral and raises the price target from $328 to $333.
02-19 02:05
RenaissanceRe (RNR) declares $0.41/share quarterly dividend, 2.5% increase from prior dividend of $0.40. Forward yield 0.54% Payable March 31; for shareholders of record March 13; ex-div March 13. See...
02-12 05:48
今日重点评级关注:HC Wainwright & Co.:维持内克塔治疗"买入"评级,目标价从135美元升至165美元;BTIG:维持内克塔治疗"买入"评级,目标价从118美元升至151美元
02-11 11:02
今日重点评级关注:瑞杰金融:上调Lumexa Imaging Holdings评级至"强力买入",目标价23美元;BTIG:维持Transocean"买入"评级,目标价从6美元升至10美元
02-10 10:29
今日重点评级关注:HC Wainwright & Co.:维持NovaBridge Biosciences"买入"评级,目标价从7美元升至9美元;Truist Securities:维持Reddit"买入"评级,目标价从270美元升至275美元
02-09 14:37
今日重点评级关注:康托·菲茨杰拉德:维持Wave Life Sciences Ltd."超配"评级,目标价从34美元升至41美元;Piper Sandler:维持Replimune Group"超配"评级,目标价从13美元升至14美元
02-06 16:52